Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI

- Asthma
- Completed

Study Title: A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)

Teva Identifier: ABS-AS-101

ClinicalTrials.gov Identifier: NCT01056159

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Albuterol dry powder inhaler | Drug: Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 18 Years to 45 Years

Trial Duration: 01/01/2010 - 06/01/2010

Phase: Phase 1

Study Type

Interventional